Conejo-García Ana, Báñez-Coronel Mónica, Sánchez-Martín Rosario M, Rodríguez-González Agustín, Ramos Angeles, Ramírez de Molina Ana, Espinosa Antonio, Gallo Miguel Angel, Campos Joaquín M, Lacal Juan Carlos
Departamento de Quimica Farmaceutica y Organica, Facultad de Farmacia, Universidad de Grenada, Campus de Cartuja s/n, 18071 Granada, Spain.
J Med Chem. 2004 Oct 21;47(22):5433-40. doi: 10.1021/jm0496537.
Studies have been aimed to establish the structure-activity relationship that define choline kinase (ChoK) inhibitory potency and antiproliferative activity of a set of 25 bispyridinium compounds with electron-releasing groups at position 4. Here we report that, according to their inhibitory activities against human ChoK, the enzymatic inhibitory potency is closely related to the size of the linker, the 3,3'-biphenyl moiety being the most suitable. The N-methylanilino and its derivatives, 4-chloro-N-methylanilino and 3,5-dichloro-N-methylanilino, render higher ChoK inhibitory and antiproliferative activities against the HT-29 human colon cancer cell line.
研究旨在建立结构-活性关系,该关系定义了一组25种在4位带有供电子基团的双吡啶化合物的胆碱激酶(ChoK)抑制效力和抗增殖活性。在此我们报告,根据它们对人ChoK的抑制活性,酶抑制效力与连接基的大小密切相关,3,3'-联苯部分是最合适的。N-甲基苯胺及其衍生物4-氯-N-甲基苯胺和3,5-二氯-N-甲基苯胺对HT-29人结肠癌细胞系具有更高的ChoK抑制和抗增殖活性。